Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Background
The Indirect Fluorescence Antibody (IFA) Test is a commonly used immunological test for detecting the presence of particular antibodies in a sample. It is a sensitive and specific approach commonly used in the diagnosis of infectious infections, autoimmune disorders and immunological studies.
The IFA test is a diagnostic method that uses specific antigen-antibody interactions, visualized using fluorescence microscopy. It involves recognizing target antigens on a substrate ensuring only specific antibodies bind. When a biological sample containing antibodies is incubated with the antigen substrate specific antibodies bind to the target antigens. A secondary antibody labeled with fluorescein isothiocyanate (FITC) binds to the Fc region of the primary antibody. Fluorescence microscopy is used to detect and visualize these complexes.
The IFA test involves several steps to ensure accurate antibody detection. Patient serum or plasma is prepared and diluted to optimize detection. The substrate which contains fixed antigens is prepared on microscope slides. Substrates can be tissue sections, cell lines, or purified antigens. Chemicals like acetone or formalin are used to preserve antigenicity. The sample is then incubated with primary antibodies and allowing specific antibodies to bind to their corresponding antigens. Excess unbound antibodies are removed using buffer washes. Secondary antibodies are applied designed to bind to the Fc region of primary antibodies amplification of the fluorescence signal. A final washing removes excess secondary antibodies to minimize background fluorescence. The slides are examined under a fluorescence microscope and a positive result is identified by the presence of fluorescence providing insights into antibody distribution and pattern.
The IFA test is a highly sensitive and specific diagnostic tool that can detect low antibody concentrations with minimal cross-reactivity. It allows for qualitative and quantitative analysis, visual localization and is versatile applicable to various diseases and research applications. Its customization allows it to be adapted for different antigens and pathogens.
The IFA test has limitations like subjectivity in interpretation, labor-intensive nature need for specialized equipment like a fluorescence microscope, potential for nonspecific binding and limited throughput making it unsuitable for high throughput testing in large-scale diagnostic settings. Additionally, the procedure requires multiple steps and may not be available in all laboratories.
Indications/Applications
Infectious disease diagnosis: Identifies pathogen-specific antibodies in bacterial, viral, parasitic and fungal infections.
Autoimmune disease assessment: Detects autoantibodies in conditions like lupus, Sjögren’s syndrome and autoimmune hepatitis.
Vaccine efficacy evaluation: Monitors antibody titers post-vaccination to assess immune responses.
Immune status monitoring: Used in immunocompromised patients or during immunotherapy.
To diagnose infectious disease:
Bacteria: Rickettsia spp., Borrelia burgdorferi (Lyme disease), Legionella pneumophila
Viruses: Cytomegalovirus (CMV), Epstein-Barr Virus (EBV)
Parasites: Toxoplasma gondii (toxoplasmosis), Plasmodium species (malaria)
Fungi: Adapted for fungal infections like coccidioidomycosis
To diagnose autoimmune disease:
Anti-Nuclear Antibodies (ANA): Diagnoses lupus, systemic sclerosis and Sjögren’s syndrome.
Anti-Glomerular Basement Membrane Antibodies: Diagnoses Goodpasture’s syndrome.
Anti-Mitochondrial Antibodies: Detects primary biliary cholangitis.
Vaccine Development and Monitoring: It evaluates immune responses in vaccine trials and monitors long-term persistence of vaccine-induced antibodies.
Clinical Immunology: It detects donor-specific antibodies in transplant recipients. It can be adapted for allergen-specific antibody detection.
Veterinary Medicine: It diagnoses diseases like canine ehrlichiosis and feline infectious peritonitis in animals.
Reference Range
Positive results: Antibody titer value above the normal range indicate the potential infection, autoimmune disease or immune response.
Negative results: Antibody titer value below normal range indicate no active infection.
Interpretation
The Immunofluorescence Assay (IFA) test is a diagnostic tool used to detect autoimmune diseases. It is based on the fluorescence intensity and antibody titers which can be negative, positive or ambiguous. Negative results indicate no detectable antibodies against the tested antigen suggesting no infection, exposure or autoimmune activity. Positive results confirm the presence of specific antibodies indicating past or active infection, autoimmune disease or immune response. Equivocal results are inconclusive and require additional testing or repeat IFA after a few weeks.
The IFA test is semi-quantitative, reporting antibody levels as dilution titers. Interpretation varies based on the titer values and the disease being investigated. Low titers indicate no significant immune response or exposure suggesting early infection if symptoms are present but antibodies have not yet reached detectable levels. Moderate titers suggest prior exposure, low-grade infection or resolving disease, requiring clinical correlation and possibly follow-up testing. High titers indicate active or recent infection, strong immune response or autoimmune activity which correlates with disease activity and severity.
Interpreting IFA test results should be done considering the patient’s clinical presentation and history. High titers in infectious diseases suggest infection while a fourfold rise confirms active infection. Elevated titers may indicate chronic or latent infection. Positive results indicate autoimmune activity with specific fluorescence patterns providing clues about the disease type. Elevated titers may correlate with worsening disease activity.
False positive in infectious disease testing can occur due to cross-reactivity with similar antigens common in regions with endemic infections or multiple autoimmune conditions. False negative may occur in early-stage infections or immunosuppressed patients due to suboptimal preparation or fluorescence detection.
Collection And Panels
Sample type: Serum or plasma
Sample collection tube: SST or red top tube
Sample volume: 2 to 5 mL
Sample storage: Store the samples in refrigerator to prevent the degradation.
Sample handling: Transport the samples at 2 to 8 °C for 48 hours and for longer duration, freeze it at -20 °C.
Modifying factors:
The Indirect Fluorescence Antibody (IFA) test is influenced by various factors, including patient-related variables, test-related factors, environmental condition and environmental conditions. Understanding these factors is crucial for accurate diagnosis and reducing false positives or negatives. Patient-related factors include immune status, stage of disease, recent vaccinations or infections, age, maternal IgG antibodies transferred through the placenta and elderly individuals. Test-related factors include quality of antigen preparation, fluorescence intensity, specificity of secondary antibodies, dilution techniques and laboratory protocols. Environmental and procedural factors include temperature and storage conditions, timing of testing, contamination, cross-reactivity and interfering substances, test interpretation. Disease-specific factors include antibody persistence, class and isotype and disease-specific factors like antibody class and isotype.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
